Clinical Pharmacology of Patients with Bleeding Disorders

Abstract

Bleeding disorders can be developed by the use of anticoagulants, inherited genetic abnormalities, or illnesses such liver disease, autoimmune illness and chronic renal disease. Hemostasis is dependent on interactions between the vascular vessel wall, active platelets, and clotting factors upon blood vessel injury. In one of these stages, bleeding disorders are the result of any obvious deficiency. The amount of severity of bleeding episodes can vary depending on vascular wall flaws, platelet problems, or clotting factor deficiencies Patients. The purpose of this article is to educate dental professionals on how to treat patients with inherited bleeding disorders.